Address

Sigvion Capital
806 West Washington Street
Suite 204
Chicago, IL 60607
United States

Open map


Recent investment activity

KANDO id: 2419

Corporate information

Registration country

Relation

Funding rounds

Series B


( )

Profile Country
AgeChem Fund LP


Investment activity status
Not investing

Selected investments

Displaying 1 - 4 of 4
Profile Country Date Funding
Kereos Inc Kereos, Inc. develops targeted molecular imaging agents and therapeutics designed to detect and treat cancer and cardiovascular disease. N/A
Logical Therapeutics Inc An early stage biotechnology company N/A
Akebia Therapeutics Inc Series B
Akebia Therapeutics Inc Series A

Past employees

Selected Products / Customers

Financials